Inventor · disambiguated record
Alla Yurevna Zenova
Also filed as: ZENOVA ALLA · ZENOVA ALLA YUREVNA
25 granted patents·7 pending applications·224 citations·filing 2009–2023
96Inventor score
Top patents by PatentIndex Score
32 records- 0197US8933236B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Jan 13, 2015·50 cites·32 claims
- 0295US11299490B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·24 claims
- 0395US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0493US8101647B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 24, 2012·35 cites·37 claims
- 0592US10246453B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·68 claims
- 0692US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 0792US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 0891US10662184B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted May 26, 2020·4 cites·3 claims
- 0991US9771376B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 26, 2017·7 cites·19 claims
- 1091US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 1190US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 1289US10745392B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 18, 2020·4 cites·47 claims
- 1389US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 1487US10005724B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2015·Granted Jun 26, 2018·6 cites·11 claims
- 1587US9630929B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2012·Granted Apr 25, 2017·11 cites·29 claims
- 1683US11325902B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·1 cites·33 claims
- 1783US9550775B2Substituted triazolopyridines and methods of use thereofGENENTECH INC·Filed 2014·Granted Jan 24, 2017·7 cites·26 claims
- 1882US10981905B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Apr 20, 2021·1 cites·54 claims
- 1982US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 2081US10125098B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Nov 13, 2018·2 cites·12 claims
- 2176US10526285B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Jan 7, 2020·1 cites·17 claims
- 2273US9458178B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·4 claims
- 2370US11149002B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 19, 2021·0 cites·13 claims
- 2469US2021093618A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2567US2020108054A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2664US11639351B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2021·Granted May 2, 2023·0 cites·18 claims
- 2764US2015224071A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2014·Application pending·0 cites
- 2862US2024101531A1Pyridinamine derivatives and their use as potassium channel modulatorsXENON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2956US2017114075A1Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3056US2017002017A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 3147US2018162868A1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3240US10179767B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jan 15, 2019·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →